NCT06693648 - A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms | Biotech Hunter

Enrollment

540

Participants

Timeline

Start Date

February 18, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

March 31, 2026

Conditions

Osteoarthritis of KneeOsteoarthritis, Knee

Interventions

DRUG

AMZ001 Diclofenac gel

Diclofenac gel applied once daily

DRUG

Placebo gel

Matching placebo gel applied once daily

Trial Locations (11)

20852

ACTIVE_NOT_RECRUITING

DelRicht Research, Rockville

28557

ACTIVE_NOT_RECRUITING

West Clinical Research, Morehead City

32750

ACTIVE_NOT_RECRUITING

Future Medical Research, Longwood

33013

ACTIVE_NOT_RECRUITING

Eastern Research Inc, Hialeah

48085

ACTIVE_NOT_RECRUITING

Oakland Medical Research, Troy

70115

ACTIVE_NOT_RECRUITING

DelRicht Research, New Orleans

91360

ACTIVE_NOT_RECRUITING

Millennium Clinical Trials, Thousand Oaks

Unknown

RECRUITING

hong Kong Center for Clinical Research, Hong Kong

RECRUITING

Charles University, Prague

RECRUITING

Sanos Clinic, Herlev

RECRUITING

Medyczne Centrum Hetmanska Piotr Leszczynski, Poznan